Recommendation to Pause Use of Johnson & Johnson’s Janssen COVID-19 Vaccine

Protection Is a Top Precedence

COVID-19 vaccine basic safety is a major precedence for the federal governing administration, and all experiences of health challenges adhering to COVID-19 vaccination are taken extremely seriously. This possible basic safety issue was caught early, and this pause displays the federal government’s motivation to transparency as CDC and Fda overview these info. COVID-19 vaccines have gone through and will carry on to undertake the most intense basic safety monitoring in U.S. history.

What to Do If You Obtained the J&J/Janssen COVID-19 Vaccine

If you received the vaccine a lot more than a few months in the past, the danger of developing a blood clot is most likely extremely very low at this time.

If you received the vaccine within just the previous a few months, your danger of developing a blood clot is also extremely very low and that danger will lessen over time.

Make contact with your health care company and find health-related remedy urgently if you build any of the adhering to signs or symptoms:

• severe headache,
• backache,
• new neurologic signs or symptoms,
• severe stomach suffering,
• shortness of breath,
• leg swelling,
• tiny red spots on the skin (petechiae), or

If you are scheduled to get the J&J/Janssen COVID-19 Vaccine, be sure to function with your vaccine company to reschedule your appointment to obtain an additional approved and suggested COVID-19 vaccine. There are two other COVID-19 vaccines approved and suggested for use in the United States: Pfizer-BioNTech and Moderna.

If you encounter any adverse events right after vaccination, report them to v-risk-free and the Vaccine Adverse Party Reporting Processexternal icon.

For Health care Providers

Health care suppliers are suggested to pause the use of the J&J/Janssen COVID-19 Vaccine. Sustain acute medical recognition of signs or symptoms that could possibly depict significant thrombotic events or thrombocytopenia in patients who have recently received the J&J/Janssen COVID-19 Vaccine, like:

• severe headache,
• backache,
• new neurologic signs or symptoms,
• severe stomach suffering,
• shortness of breath,
• leg swelling,
• petechiae, or
• new or straightforward bruising.

Read through the official CDC health notify, Situations of Cerebral Venous Sinus Thrombosis with Thrombocytopenia right after Receipt of the Johnson & Johnson COVID-19 Vaccine, which features aspects about how to cope with a patient that presents with thrombosis or thrombocytopenia.

Report adverse events to the Vaccine Adverse Party Reporting Processexternal icon.

For Vaccine Providers

Be sure to function with folks who ended up scheduled to obtain the J&J/Janssen COVID-19 Vaccine in the days forward to reschedule their appointments to obtain an additional approved and suggested COVID-19 vaccine (i.e., Pfizer-BioNTech, Moderna).